BOSTON SCIENTIFIC CORP is 2.5x more valuable than RESMED INC by market capitalization ($71.33 B vs $28.08 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | RMD | BSX |
|---|---|---|
| Market cap | $28.08 B | $71.33 B |
| US-listed rank | #490 | #239 |
| Revenue (latest FY) | $5.15B | $20.07B |
| Net income (latest FY) | $1.40B | - |
| Net margin | 27.2% | - |
| P/E (trailing FY) | 20.0 | - |
| SEC filings | 2,518 | 1,009 |
BOSTON SCIENTIFIC CORP is 2.5x more valuable than RESMED INC by market capitalization ($71.33 B vs $28.08 B).
In their latest fiscal years, RESMED INC reported $5.15B in revenue while BOSTON SCIENTIFIC CORP reported $20.07B.
Full pages: RESMED INC and BOSTON SCIENTIFIC CORP, or browse the full rankings.